Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > This is where the game gets played

<< Previous

Bullboard Posts

Next >>

Comment by RODBUSTERon Jul 25, 2018 10:29am

100 Views

Post# 28364285

RE:RE:RE:RE:This is where the game gets played

14 and 17 has become major resistance
Think about it, how many here just on this board alone want out and didn’t pull the trigger

Short volume was 40 million in 2 weeks, that’s insane
Guess who is dumping right now, shorts and making money and bagholders are in awe

The pump machine will tell you it was going to the moon, but in reality, if anybody here would of took the time checking shortdata, they would of known this was coming

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading